American Healthcare REIT, Inc. AHR
52.02
(0.29)
(0.55%)
as of 25 Sep
- Market cap
- $11.5B
- P/E
- 76.5×
Follow AHR
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
300.07 | 114.78 | 81.31 | 76.69 |
P/S ratio |
3.23 | 3.46 | 3.73 | 4.02 | |
P/FCF ratio |
19.61 | 36.16 | 42.10 | 46.39 | |
P/Operating CF |
66.24 | 141.66 | 108.97 | 84.72 | |
P/B ratio |
2.61 | 2.33 | 2.51 | 2.69 | |
Price to Tangible BV |
3.08 | 2.72 | 2.91 | 3.07 | |
EV/Sales |
3.85 | 4.08 | 4.31 | 4.52 | |
EV/EBITDA |
22.02 | 23.69 | 24.67 | 25.67 | |
EV/Operating CF |
28.35 | 31.29 | 32.47 | 31.21 | |
EV/FCF |
23.40 | 42.64 | 48.72 | 52.16 | |
Quick Ratio |
0.44 | 0.41 | 0.45 | 0.48 | |
Current Ratio |
0.44 | 0.41 | 0.45 | 0.48 | |
Net Debt/EBITDA |
13.55 | 13.90 | 12.09 | 10.12 | |
Debt/Assets |
32.60% | 28.58% | 27.61% | 25.29% | |
Debt/Equity |
0.57 | 0.46 | 0.44 | 0.39 | |
Asset Turnover |
0.47 | 0.46 | 0.47 | 0.49 | |
Operating CF/Net income |
1.92 | 5.12 | 3.42 | 3.88 | |
Capex/Depreciation |
(0.38) | (0.69) | (0.50) | (0.50) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.46% | 2.74% | 2.71% | 2.95% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.09 | 0.08 | |
Share Based Compensation of Revenue |
0.60% | 0.90% | 0.75% | 0.86% | |
Graham Net Nets |
(0.24) | (0.22) | (0.19) | (0.15) | |
Graham Number |
7.12 | 13.66 | 15.66 | 17.24 | |
Earnings Yield |
0.33% | 0.87% | 1.23% | 1.30% | |
Free Cash Flow Yield |
5.10% | 2.77% | 2.38% | 2.16% | |
Revenue per Share |
3.39 | 3.64 | 3.47 | 3.50 | |
Operating CF per Share |
0.63 | 0.33 | 0.43 | 0.62 | |
Capex per Share |
(0.13) | (0.27) | (0.20) | (0.21) | |
Free Cash Flow per Share |
0.50 | 0.06 | 0.23 | 0.41 | |
Cash per Share |
1.09 | 0.91 | 0.84 | 0.99 | |
Shareholders Equity per Share |
16.09 | 20.24 | 18.80 | 19.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.09 | 20.24 | 18.80 | 19.42 | |
Free Cash Flow |
84.99 | 10.66 | 42.75 | 78.24 | |
Working Capital |
(474.78) | (511.44) | (491.60) | (460.76) | |
Capital Expenditures |
(22.20) | (44.50) | (38.32) | (40.38) | |
Net Current Asset Value |
(1,677.39) | (1,709.54) | (1,678.82) | (1,540.77) | |
EV/EBIT |
50.82 | 56.26 | 62.26 | 70.54 | |
Capex to Sales |
0.04 | 0.07 | 0.06 | 0.06 | |
Net Profit Margin |
9.76% | 1.78% | 3.64% | 4.54% | |
Price to Operating Income |
42.60 | 47.72 | 53.80 | 62.73 | |
| Other line items | |||||
Average Receivables |
196.14 | 207.71 | 232.13 | 226.85 | |
Average Payables |
283.92 | 288.03 | 306.27 | 302.92 | |
Average Assets |
4,723.65 | 4,957.14 | 5,031.35 | 5,105.28 | |
Average Common Equity |
2,488.45 | 2,832.28 | 2,912.92 | 3,102.27 |
Columns are period end dates